Related Experiment Video

Updated: May 2, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

12.4K

CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis

Zesong Li1, Jun Xie2, Jianting Wu3

  • 1Shenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, China.

Plos One
|March 4, 2014
PubMed

Insights

The CMTM3 gene acts as a tumor suppressor in testicular cancer, frequently silenced by promoter methylation. Restoring CMTM3 expression halts cancer cell growth and triggers apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The role of CMTM3 (Cochaperone Molecule That Interacts With Protein Kinase C and Transmembrane Protein 3) as a tumor suppressor is suggested, with its loss observed in various carcinomas.
  • However, the regulation and function of CMTM3 in tumor progression are not well understood, particularly in testicular cancer.

Purpose of the Study:

  • To investigate the regulation, function, and molecular mechanisms of CMTM3 in human testicular cancer cells.
  • To determine if CMTM3 acts as a tumor suppressor in this context.

Main Methods:

  • Analysis of CMTM3 expression in testicular cancer cell lines and tissues compared to normal testis tissues.
  • Functional studies involving re-expression of CMTM3 in cancer cells to assess effects on proliferation, colony formation, and migration.
  • Investigation of cell cycle progression, apoptosis markers (caspases, PARP), and the p53/p21 pathway.
  • Analysis of CpG island methylation in the CMTM3 promoter region in clinical tumor samples.

Main Results:

  • CMTM3 was significantly downregulated or silenced in testicular cancer cell lines and tumor tissues, but highly expressed in normal testis.
  • Re-expression of CMTM3 suppressed colony formation, proliferation, and migration, inducing G2 cell cycle arrest and apoptosis.
  • CMTM3 re-expression activated p53 transcription, increased p53 accumulation, upregulated p21, and enhanced caspase and PARP cleavage.
  • Downregulation of CMTM3 in tumors correlated with methylation of a specific CpG site in the core promoter's Sp1/Sp3-responsive region.

Conclusions:

  • CMTM3 functions as a tumor suppressor in testicular cancer by inducing G2 cell cycle arrest and apoptosis.
  • CMTM3 is involved in testicular cancer pathogenesis and is frequently silenced by promoter methylation.
  • Targeting CMTM3 or its regulatory mechanisms could offer therapeutic strategies for testicular cancer.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K